Last week PCB senior scientist, Dr. Jinu Abraham, presented his invited talk entitled, "Rapid Preclinical development of targeted therapy combination for DIPG" at the DIPG Consensus Conference, which was held October 6-7th at NIH's Bethesda campus. A subject of the conference was determining the role of biopsy in the standard of care for this form of brainstem high grade glioma. Noted to be equally important, however, is the search for a combination of targeted agents that makes this tumor a uniformly survivable condition.
No comments:
Post a Comment